MX358980B - Colocacion optimizada de canula para suministro de terapeuticos al cerebro. - Google Patents

Colocacion optimizada de canula para suministro de terapeuticos al cerebro.

Info

Publication number
MX358980B
MX358980B MX2012002423A MX2012002423A MX358980B MX 358980 B MX358980 B MX 358980B MX 2012002423 A MX2012002423 A MX 2012002423A MX 2012002423 A MX2012002423 A MX 2012002423A MX 358980 B MX358980 B MX 358980B
Authority
MX
Mexico
Prior art keywords
brain
delivery
cannula
therapeutics
placement
Prior art date
Application number
MX2012002423A
Other languages
English (en)
Other versions
MX2012002423A (es
Inventor
S Bankiewicz Krystof
Yin Dali
Original Assignee
The Regents Of The Univ Of California Star
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The Univ Of California Star filed Critical The Regents Of The Univ Of California Star
Publication of MX2012002423A publication Critical patent/MX2012002423A/es
Publication of MX358980B publication Critical patent/MX358980B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
    • A61B5/4064—Evaluating the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/10—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges for stereotaxic surgery, e.g. frame-based stereotaxis
    • A61B90/11—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges for stereotaxic surgery, e.g. frame-based stereotaxis with guides for needles or instruments, e.g. arcuate slides or ball joints
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/10—Computer-aided planning, simulation or modelling of surgical operations
    • A61B2034/101—Computer-aided simulation of surgical operations
    • A61B2034/105—Modelling of the patient, e.g. for ligaments or bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36—Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37—Surgical systems with images on a monitor during operation
    • A61B2090/374—NMR or MRI
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychology (AREA)
  • Genetics & Genomics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Primary Health Care (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporcionan métodos y sistemas para el suministro mejorado de agentes a las regiones seleccionadas del cerebro, por el uso de las coordenadas de colocación que proporcionan la colocación óptima de la cánula de suministro. Optimizando la colocación de cánula, se alcanza la distribución reproducible de la infusión en la región seleccionada del cerebro, permitiendo un suministro más efectivo de los terapéuticos al cerebro.
MX2012002423A 2009-08-25 2010-08-25 Colocacion optimizada de canula para suministro de terapeuticos al cerebro. MX358980B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27520909P 2009-08-25 2009-08-25
PCT/US2010/046680 WO2011025836A1 (en) 2009-08-25 2010-08-25 Optimized placement of cannula for delivery of therapeutics to the brain

Publications (2)

Publication Number Publication Date
MX2012002423A MX2012002423A (es) 2012-09-07
MX358980B true MX358980B (es) 2018-09-11

Family

ID=43628370

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012002423A MX358980B (es) 2009-08-25 2010-08-25 Colocacion optimizada de canula para suministro de terapeuticos al cerebro.

Country Status (11)

Country Link
US (2) US20120209110A1 (es)
EP (1) EP2470250A4 (es)
JP (1) JP5847717B2 (es)
KR (1) KR101649145B1 (es)
CN (1) CN102573979B (es)
AU (1) AU2010286668B2 (es)
BR (1) BR112012004166A8 (es)
CA (1) CA2771175C (es)
CL (1) CL2012000435A1 (es)
MX (1) MX358980B (es)
WO (1) WO2011025836A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8734809B2 (en) 2009-05-28 2014-05-27 University Of Massachusetts AAV's and uses thereof
ES2854832T3 (es) * 2011-08-01 2021-09-23 Alcyone Lifesciences Inc Dispositivos microfluídicos de administración de medicamentos
EP2810197B1 (en) * 2012-02-02 2018-04-04 Brainlab AG Method for determining an infusion parameter
US9020224B2 (en) 2012-04-27 2015-04-28 Medtronic, Inc. Volume of efficacy model capture
US9393361B2 (en) 2012-12-14 2016-07-19 Medtronic, Inc. Method to determine a material distribution
US9008752B2 (en) 2012-12-14 2015-04-14 Medtronic, Inc. Method to determine distribution of a material by an infused magnetic resonance image contrast agent
ES2869328T3 (es) 2012-12-18 2021-10-25 Alcyone Lifesciences Inc Dispositivos y métodos para reducir o evitar un reflujo en un sistema de administración
US20140255471A1 (en) 2013-03-11 2014-09-11 Wake Forest University Health Sciences Method of treating brain tumors
PL2970492T3 (pl) 2013-03-15 2019-10-31 Univ Wake Forest Health Sciences Przeciwciała przeciwko ludzkim i psim il-13ra2
WO2014171826A1 (en) 2013-04-17 2014-10-23 Stichting Vu-Vumc Treatment of cognitive impairment in depressive disorders
EP2991560B1 (en) 2013-04-30 2020-07-29 Cedars-Sinai Medical Center Stabilization apparatuses for medical procedures
GB201308917D0 (en) * 2013-05-17 2013-07-03 Renishaw Plc Delivery
CA3120114A1 (en) 2013-06-17 2014-12-24 Alcyone Lifesciences, Inc. Methods and devices for protecting catheter tips and stereotactic fixtures for microcatheters
ES2738298T3 (es) 2013-07-31 2020-01-21 Alcyone Lifesciences Inc Sistemas y métodos de suministro de fármacos, tratamiento y monitoreo
WO2015067299A1 (en) * 2013-11-05 2015-05-14 Brainlab Ag Quantification of brain vulnerability
WO2015070210A1 (en) 2013-11-11 2015-05-14 Wake Forest University Health Sciences Epha3 and multi-valent targeting of tumors
EP3209311B1 (en) 2014-10-21 2024-03-06 University of Massachusetts Recombinant aav variants and uses thereof
CN107106814B (zh) 2014-10-29 2021-02-26 西达-赛奈医疗中心 一种用于治疗剂和相关物质的受控输送的设备、系统和方法
WO2016077607A1 (en) 2014-11-13 2016-05-19 The Regents Of The University Of California Adjustable stepped cannula
US10806396B2 (en) * 2015-01-26 2020-10-20 Alcyone Lifesciences, Inc. Drug delivery methods with tracer
WO2016163886A2 (en) 2015-04-10 2016-10-13 Clues2Cure International B.V. Administration of taurine or an analog thereof for the treatment of nerve cell damage
JP2018535004A (ja) * 2015-10-30 2018-11-29 シーダーズ−サイナイ メディカル センター 組織リトラクタシステム及び方法
CA3008680A1 (en) 2016-01-04 2017-07-13 Alcyone Lifesciences, Inc. Methods and devices for treating stroke
EP3506817A4 (en) 2016-08-30 2020-07-22 The Regents of The University of California METHOD FOR BIOMEDICAL TARGETING AND RELEASE, AND DEVICES AND SYSTEMS FOR IMPLEMENTING THEM
AU2017341849B2 (en) 2016-10-13 2024-03-21 University Of Massachusetts AAV capsid designs
WO2018111099A1 (en) 2016-12-12 2018-06-21 Stichting Vumc Biomarkers and treatments for cerebral amyloid angiopathy (caa)
JP7229989B2 (ja) 2017-07-17 2023-02-28 ボイジャー セラピューティクス インコーポレイテッド 軌道アレイガイドシステム
CN108186133B (zh) * 2017-12-05 2020-12-01 广东省实验动物监测所 非人灵长类动物脑黑质区的定位方法
US11550012B2 (en) * 2018-06-11 2023-01-10 Canon Medical Systems Corporation Magnetic resonance imaging apparatus and imaging processing method for determining a region to which processing is to be performed
AU2019359377A1 (en) * 2018-10-10 2021-05-20 The Research Foundation For Mental Hygiene, Inc. System, method and computer-accessible medium for neuromelanin-sensitive magnetic resonance imaging as a non-invasive proxy measure of dopamine function in the human brain
WO2021102422A1 (en) * 2019-11-22 2021-05-27 The Brigham And Women's Hospital, Inc. Systems and methods for ventricle procedures
US12079960B2 (en) 2021-03-11 2024-09-03 Terran Biosciences Inc. Systems, devices, and methods for harmonization of imaging datasets including biomarkers

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7505807B1 (en) * 1997-05-15 2009-03-17 Regents Of The University Of Minnesota Magnetic resonance apparatus for use with active electrode and drug deliver catheter
ES2324540T3 (es) * 1998-05-27 2009-08-10 Genzyme Corporation Vectores aav para la fabricacion de medicamentos para la administracion potenciada por conveccion.
US20040092879A1 (en) * 2000-11-06 2004-05-13 Medamicus, Inc. Safety introducer apparatus and method therefor
WO2003004660A1 (en) * 2001-07-03 2003-01-16 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods of administering vectors to synaptically connected neurons
GB0205773D0 (en) * 2002-03-12 2002-04-24 Gill Steven S Clamp
AU2003299140B2 (en) * 2002-09-24 2008-07-17 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for convection enhanced delivery of therapeutic agents
EP1786320B1 (en) * 2004-07-27 2016-09-14 MRI Interventions, Inc. Mri systems having mri compatible universal delivery cannulas with cooperating mri antenna probes and related systems and methods
US8391959B2 (en) * 2004-09-29 2013-03-05 Tel Hashomer Medical Research Infrastructure And Services Ltd. Composition for improving efficiency of drug delivery
CN101123919A (zh) * 2004-10-05 2008-02-13 建新公司 台阶式插管
AU2006283189B2 (en) * 2005-08-23 2013-01-31 The Regents Of The University Of California Reflux resistant cannula and system for chronic delivery of therapeutic agents using convection-enhanced delivery
EP1788498A1 (en) * 2005-11-21 2007-05-23 BrainLAB AG Apparatus for infusing substances
WO2007127839A2 (en) * 2006-04-26 2007-11-08 The Regents Of The University Of California Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics
US8150498B2 (en) * 2006-09-08 2012-04-03 Medtronic, Inc. System for identification of anatomical landmarks
DE602008003941D1 (de) * 2007-04-13 2011-01-27 Brainlab Ag Verfahren und Vorrichtung für die Planung lokaler Verabreichung eines Arzneimittels
CA2701744A1 (en) * 2007-10-08 2009-04-16 Renishaw (Ireland) Limited Catheter

Also Published As

Publication number Publication date
WO2011025836A1 (en) 2011-03-03
KR20120089457A (ko) 2012-08-10
US20180344199A1 (en) 2018-12-06
JP2013502997A (ja) 2013-01-31
MX2012002423A (es) 2012-09-07
CL2012000435A1 (es) 2012-10-12
AU2010286668A1 (en) 2012-03-08
AU2010286668B2 (en) 2015-04-09
EP2470250A1 (en) 2012-07-04
CN102573979A (zh) 2012-07-11
EP2470250A4 (en) 2013-07-17
BR112012004166A8 (pt) 2016-10-04
CN102573979B (zh) 2016-01-13
JP5847717B2 (ja) 2016-01-27
KR101649145B1 (ko) 2016-08-18
US20120209110A1 (en) 2012-08-16
CA2771175A1 (en) 2011-03-03
CA2771175C (en) 2017-12-05
BR112012004166A2 (pt) 2016-03-29

Similar Documents

Publication Publication Date Title
MX358980B (es) Colocacion optimizada de canula para suministro de terapeuticos al cerebro.
MX346439B (es) Métodos y medios para modificar un genoma vegetal.
IN2014CN02887A (es)
AU2011328009A8 (en) Compounds and methods for treating pain
MX345747B (es) Dispositivo de inyección automático portable.
MX356525B (es) Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia.
MX2014000129A (es) Combinaciones de farmacos y su usos en el tratamiento de una condicion de tos.
MX2013009068A (es) Compuestos y metodos para la modulacion de quinasas e indicaciones para los mismos.
MX2013003076A (es) Terapeuticos contra cancer de mama.
MY170934A (en) Treatment of pain associated with dislocation of basal endometrium
MX353964B (es) Agentes terapeuticos y usos de los mismos.
EP2582682A4 (en) METHOD FOR THE TREATMENT OF LUNG DISEASES
WO2010085665A3 (en) Targeted delivery system
MX2015004389A (es) Metodos y composiciones para tratar esclerosis multiple y trastornos relacionadods.
SG10201810575WA (en) Treatment of prostate cancer with tor kinase inhibitors
NZ609594A (en) Eph receptor expression in tumor stem cells
MX2013006319A (es) Composiciones y metodos para tratar el cancer usando un inhibidor de pi3k y un inhibidor de mek.
MD20140004A2 (en) Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia
MX2011008994A (es) Metodos de usar sns - 595 para el tratamiento de sujetos con cancer con actividad reducida de brca2.
MX354667B (es) Metodos para el tratamiento de un impedimento sensorial-motriz relacionado con el accidente cerebrovascular con el uso de aminopiridinas.
WO2012006585A3 (en) Use of interleukin-15 to treat cardiovascular diseases
MX362111B (es) Un metodo para mejorar la funcion hepatica.
TN2014000418A1 (en) Methods for treating cancer using pi3k inhibitor and mek inhibitor
UA58066U (ru) Способ лечения генитальной вирусной инфекции
UA38340U (ru) Способ лечения женщин с патологическим прелиминарным периодом

Legal Events

Date Code Title Description
FG Grant or registration